About Bio-Sourcing
Bio-Sourcing is an Agriculture company based in Liege (Belgium) founded in 2014. Biopharmaceuticals for animals are manufactured and supplied through partnerships. Bio-Sourcing has raised $17.36 million across 3 funding rounds from investors including European Union, Equitis and Nausicaa Ventures. Bio-Sourcing offers products and services including BioMilk Platform. Its focus areas include Food and Agriculture Tech, Livestock Tech, Health Management and Pharmaceuticals. Its legal entity is BioSourcing SA. Its competitors include Zoetis and Animab; 1 of its 2 listed competitors has raised funding.
Company details
Bio-Sourcing was established in 2014 in Liege, Belgium, within the biopharmaceutical sector focused on animal health. Veterinary biopharmaceuticals are produced and distributed by the company. Collaborations with various animal health firms have been formed to adapt human therapeutic treatments into biological drugs suitable for animals. Operations center on manufacturing, supply chain management, and innovation in animal therapeutics across Europe.
- Headquarters Liege, Belgium
- SectorsAgriculture
- Email••••••••
- Website bio-sourcing.com
- Social LinkedIn
- Legal Name Biosourcing Sa
- Total Equity Funding$17.36M (USD)
in 3 rounds
- Latest Funding Round$2.78M (USD), Grant
Sep 2024
- InvestorsEuropean Union
& 4 more
Products & Services of Bio-Sourcing
Bio-Sourcing offers a comprehensive portfolio of products and services, including BioMilk Platform.
Platform uses gene-editing for affordable protein expression in goat milk.
Funding Insights of Bio-Sourcing
Bio-Sourcing has successfully raised a total of $17.36M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.78 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.36M
- Total Rounds 3
- Last Round Grant — $2.78M
- First Round $6.24M
(Nov 2014)
- Investors Count 5
All 3 funding rounds of Bio-Sourcing with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $11.13M | Series A | – | European Union | – |
| Sep 2024 | $2.78M | Grant | – | – | |
| Nov 2014 | $6.24M | Series A | – | Nausicaa Ventures, Equitis | – |
5 investors in total: 5 institutional.
Investors in Bio-Sourcing
Bio-Sourcing has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Equitis and Nausicaa Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
An early stage venture capital fund is managed by Nausicaa Ventures. | 2009 | nausicaa-ventures.be | Louvain-la-Neuve, Belgium | |
Noshaq is recognized as a Liège-based investment fund providing financing solutions. | noshaq.be | Liege, Belgium | ||
| spinventure.be | ||||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Asset management services are provided by Equitis in Paris. | 2000 | equitis.fr | Paris, France |
Investor details for Bio-Sourcing
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bio-Sourcing
3 dated milestones of Bio-Sourcing across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Bio-Sourcing is founded.
- Funding First funding round of $6.2M.
- Funding Latest funding round, Grant, of $2.8M.
Competitors of Bio-Sourcing
Bio-Sourcing has 2 listed competitors in our database, 1 of them funded. They include Zoetis and Animab.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zoetis.com | 2012 | Brussels, Belgium | 9,200 | Animal medicines, vaccines, and diagnostics are manufactured and supplied. | ||
| animab.com | 2020 | Ghent, Belgium | $13.97M | 3 | Proprietary monoclonal antibody platform is provided for pig intestinal infections. |
Detailed competitors of Bio-Sourcing
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bio-Sourcing
Complete news archive for Bio-Sourcing
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bio-Sourcing
Bio-Sourcing was founded in 2014.
Bio-Sourcing is headquartered in Liege, Belgium. It is registered at Liege, Liege, Belgium.
Bio-Sourcing is a funded company, having raised a total of $17.36M across 3 funding rounds to date. The company's 1st funding round was a Series A of $6.24M, raised on Nov 2014.
Bio-Sourcing was established in 2014 in Liege, Belgium, within the biopharmaceutical sector focused on animal health. Veterinary biopharmaceuticals are produced and distributed by the company. Collaborations with various animal health firms have been formed to adapt human therapeutic treatments into biological drugs suitable for animals. Operations center on manufacturing, supply chain management, and innovation in animal therapeutics across Europe.
Bio-Sourcing offers BioMilk Platform.
Bio-Sourcing has 5 investors. Key investors include European Union, Equitis, Nausicaa Ventures, Noshaq, and Spinventure.
Bio-Sourcing operates through Biosourcing Sa.